Pier 88 Investment Partners’s Health Catalyst HCAT Stock Holding History

Pier 88 Investment Partners’s Portfolio HCAT Stock Details HCAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-134,060	Closed	-$505K	–	120
2025 Q2	$505K	Sell	134,060 -95,810	-42%	-$377K	0.09%	89
2025 Q1	$1.04M	Buy	229,870 +58,980	+35%	+$312K	0.2%	49
2024 Q4	$1.21M	Buy	170,890 +7,450	+5%	+$59.3K	0.24%	47
2024 Q3	$1.33M	Buy	163,440 +33,200	+25%	+$240K	0.29%	43
2024 Q2	$832K	Buy	130,240 +93,190	+252%	+$598K	0.19%	64
2024 Q1	$279K	Buy	37,050 +7,950	+27%	+$72.6K	0.07%	81
2023 Q4	$269K	Sell	29,100 -72,370	-71%	-$591K	0.07%	78
2023 Q3	$1.03M	Buy	101,470 +11,080	+12%	+$132K	0.26%	64
2023 Q2	$1.13M	Buy	90,390 +35,770	+65%	+$426K	0.28%	59
2023 Q1	$637K	Buy	+54,620	New	+$696K	0.15%	64

Other funds holding HCAT

FLAM

First Light Asset Management Edina, Minnesota $1.65B AUM 203.21% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WCA

Whetstone Capital Advisors Shawnee Mission, Kansas $380M AUM 20.01% 1-Year Est. Return

Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

Pier 88 Investment Partners's HCAT Position: Q3 2025 in Review

Pier 88 Investment Partners sold out of Health Catalyst (HCAT) in Q3 2025, closing a stake of 134,060 shares — an estimated $505K sold.

Pier 88 Investment Partners first reported a position in HCAT in Q1 2023 and held it in 10 quarters. The position peaked at $1.33M in Q3 2024. 145 funds tracked by Wall St. Rank hold HCAT as of Q3 2025.

Pier 88 Investment Partners reported no remaining Health Catalyst position as of Q3 2025 after selling out during the quarter.
Pier 88 Investment Partners sold 134,060 Health Catalyst shares in Q3 2025, an estimated $505K.
Pier 88 Investment Partners first reported a position in Health Catalyst in Q1 2023 and held it in 10 quarters.
Pier 88 Investment Partners's Health Catalyst position peaked at $1.33M in Q3 2024.
145 funds tracked by Wall St. Rank held Health Catalyst as of Q3 2025.

Based on Pier 88 Investment Partners's 13F filing for Q3 2025, filed 31 Oct 2025.